On September 14, Council for EconomicPlanning and Development (CEPD) minister Ho Mei-yueh, TaiMed Biologics chairwoman Tsai Ing-wen, Academia Sinica president Wong Chi-huey, and Academician David Ho held a press conference to announce that TaiMed Biologics had been licensed by Genentech, the world's largest biotechnology corporation, to produce TNX-355, a new drug for treating HIV and AIDS.
9 月 14 日，經建會主委何美玥、宇昌生技公司董事長蔡英文、中研院院長翁啟惠及院士何大一，史無前例地聯合召開記者會，宣布宇昌生技獲得全球最大生技公司、美商 Genentech 授權，將生產治療人類後天免疫不全病毒（HIV）感染及愛滋病的新藥物「TNX ─ 355」。